AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Razma D 30mg/20mg Capsule SR

Prescription Icon
Prescription Required

Marketer

Acme Pharmaceutical

Salt Composition

Domperidone (30mg) + Rabeprazole (20mg)

Overview Razma D 30mg/20mg Capsule SR

Gastroesophageal reflux disease (GERD), or acid reflux, can be managed with the combined-action capsule, Razma D SR 30mg/20mg. This medication targets acidity symptoms like heartburn, stomach upset, and irritation by neutralizing stomach acid and facilitating gas expulsion for improved comfort. Dosage and duration for Razma D SR 30mg/20mg capsules are prescribed by your physician, based on your individual needs and response. Consistent use, as directed, is crucial; premature discontinuation may lead to symptom recurrence and condition exacerbation. Always inform your doctor of any other medications you're using, as interactions are possible. Common, typically transient side effects include diarrhea, abdominal pain, dry mouth, headache, gas, and fatigue. Report any concerning side effects promptly. Due to potential drowsiness and dizziness, avoid driving or activities requiring alertness until the drug's effects are known. Alcohol consumption should be avoided due to increased sedation risk. Lifestyle adjustments, such as consuming cool milk and omitting hot beverages, spicy foods, and chocolate, can enhance treatment outcomes. Prior to commencing Razma D SR, disclose any existing kidney or liver conditions, and inform your doctor about pregnancy, pregnancy planning, or breastfeeding.

Uses of Razma D 30mg/20mg Capsule SR

Managing gastroesophageal reflux and peptic ulcers.

Major Benefits of Razma D 30mg/20mg Capsule SR:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the entire capsule without chewing, crushing, or breaking it. Administer Razma D 30mg/20mg Capsule SR on an empty stomach.

Common Side effects of Razma D 30mg/20mg Capsule SR:

  • Cough
  • Headache
  • Diarrhea
  • Dizziness
  • Inflammation of the nose
  • Abdominal pain
  • Vomiting
  • Weakness
  • Nasal congestion (stuffy nose)
  • Insomnia (difficulty in sleeping)
  • Fundic gland polyps
  • Nausea
  • Constipation
  • Flatulence
  • Back pain
  • Pharyngitis

How to use Razma D 30mg/20mg Capsule SR:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Razma D 30mg/20mg SR Capsule whole; avoid chewing, crushing, or breaking it. Administer on an empty stomach.

How Razma D 30mg/20mg Capsule SR works:

Razma D 30mg/20mg sustained-release capsules contain Domperidone and Rabeprazole. Domperidone, a gastrointestinal motility stimulant, enhances upper digestive tract movement, facilitating smoother food passage. Rabeprazole, a proton pump inhibitor (PPI), decreases stomach acid production, providing relief from acid indigestion and heartburn.

SAFETY ADVICE

AlcoholAlcoholCAUTION

Exercise caution when using Razma D 30mg/20mg SR capsules concurrently with alcohol. Seek medical advice.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Razma D 30mg/20mg SR Capsules during pregnancy might pose risks. While human research is scant, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against possible hazards prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The prolonged-release Razma D 30mg/20mg capsule is likely unsafe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a risk to the infant.

DrivingDrivingUNSAFE

Driving should be avoided if you experience drowsiness, blurred vision, or dizziness after taking a Razma D 30mg/20mg sustained-release capsule, as these side effects can impair alertness.

KidneyKidneyCAUTION

Individuals with kidney impairment should exercise caution when using Razma D 30mg/20mg sustained-release capsules. Dosage modifications for Razma D 30mg/20mg sustained-release capsules may be necessary. Physician consultation is advised.

LiverLiverCAUTION

Patients with liver impairment should exercise caution when using Razma D 30mg/20mg SR capsules; dosage modification may be necessary. Consult a physician before use. Razma D 30mg/20mg SR capsules are contraindicated for individuals with moderate to severe hepatic dysfunction.

What if you forget to take Razma D 30mg/20mg Capsule SR :

Should you forget to take your Razma D 30mg/20mg SR Capsule, ingest it immediately upon remembering. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Razma D 30mg/20mg Capsule SR

LabelValue
Addictive None.
Medication Classification Digestive system

FAQs on Razma D 30mg/20mg Capsule SR

Razma D 30mg/20mg sustained-release capsules contain domperidone and rabeprazole. This dual medication treats heartburn, acid reflux (GERD—a condition causing stomach acid to back up into the esophagus), and gastric and duodenal ulcers. Domperidone alleviates vomiting by stimulating gastrointestinal motility, facilitating efficient food passage through the stomach.
Patients with hypersensitivity to rabeprazole, domperidone, or any inactive component of Razma D 30mg/20mg Capsule SR should avoid its use. Individuals with pre-existing kidney or liver conditions require careful monitoring when considering this medication.
Dry mouth is a potential side effect of Razma D 30mg/20mg SR Capsules, specifically attributed to the Domperidone component. Increased water consumption is recommended to alleviate this dryness, including keeping water readily available overnight. Reducing alcohol consumption and abstaining from smoking are also advised. For dry mouth relief, opt for alcohol-free mouthwash to minimize the risk of dental caries.
Diarrhea is a possible side effect of Razma D 30mg/20mg SR Capsules. If diarrhea occurs, increased fluid intake is recommended. Fatty or fried foods should be avoided while taking this medication. Consult your physician if diarrhea continues or if dehydration symptoms, such as reduced urination and dark, strong-smelling urine, appear.
Retain this medication within its original, sealed container or packaging. Follow the storage guidelines provided on the packaging or label. Discard any remaining medication. Ensure it remains inaccessible to children, pets, and other individuals.
Razma D 30mg/20mg SR capsules are generally well-tolerated. Nevertheless, some individuals may experience common adverse effects such as diarrhea, abdominal pain, gas, dry mouth, vertigo, or headache. Less frequent or rare side effects are also possible. Report any ongoing issues to your physician.
Optimal absorption of Razma D 30mg/20mg SR Capsules is achieved by administering them prior to the initial meal or while fasting.
Taking Razma D 30mg/20mg Capsule SR may raise the likelihood of experiencing an irregular heartbeat, a potentially serious condition. While this side effect is uncommon, it's a possibility. The risk might be somewhat greater for individuals over sixty.
Razma D 30mg/20mg sustained-release capsules contain domperidone and rabeprazole. This dual-action formulation manages acid reflux and heartburn, including gastroesophageal reflux disease (GERD) – a condition characterized by stomach acid rising into the esophagus. It's also indicated for gastric and duodenal ulcers. Domperidone's action facilitates improved gut motility, easing food passage through the stomach and thus mitigating nausea and vomiting.
Patients exhibiting hypersensitivity to rabeprazole, domperidone, or any excipients within Razma D 30mg/20mg Capsule SR should avoid its use. Individuals with pre-existing hepatic or renal impairment require careful monitoring when considering this medication.
Dry mouth is a potential side effect of Razma D 30mg/20mg SR Capsules, specifically attributed to the Domperidone component. To alleviate this, increase your water intake, keeping a glass readily available, especially overnight. Reducing alcohol consumption and abstaining from smoking are also recommended. If experiencing dry mouth, opt for alcohol-free mouthwash to minimize the chance of dental problems.
Diarrhea is a possible side effect of Razma D 30mg/20mg SR Capsules. If diarrhea occurs, increase your fluid intake. Oily or greasy foods should be avoided while taking this medicine. Consult your physician if diarrhea continues or if you observe dehydration symptoms such as reduced urination and dark, strong-smelling urine.
Razma D 30mg/20mg SR capsules are generally well-tolerated. Nevertheless, some individuals may experience common adverse reactions such as abdominal pain, diarrhea, flatulence, dry mouth, dizziness, or headache. Less frequent or rare side effects are also possible. Report any ongoing issues to your physician during treatment.
Optimal administration of Razma D 30mg/20mg sustained-release capsules is before breakfast or on an empty stomach.
Taking Razma D 30mg/20mg SR capsules may raise the likelihood of an irregular heart rhythm (severe arrhythmia). While this is a serious potential adverse effect, the probability is quite small. The risk might be marginally greater for individuals over sixty.
Store this medication in its original, tightly sealed container, following all storage instructions provided on the packaging. Discard any remaining medication and ensure it remains inaccessible to children, pets, and other individuals.
Razma D 30mg/20mg Capsule...
79
MRP 96
17% off